AIP
TAK icon

Ahrens Investment Partners’s Takeda Pharmaceutical TAK Stock Holding History

Ahrens Investment Partners’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$1.04K Buy
+63
New +$1K ﹤0.01% 944
2022
Q3 		– Sell
-63
Closed -$1K – 807
2022
Q2 		$1K Hold
63
– – ﹤0.01% 942
2022
Q1 		$1K Sell
63
-8
-11% -$117 ﹤0.01% 1008
2021
Q4 		$1K Buy
+71
New +$996 ﹤0.01% 1017

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Ahrens Investment Partners's TAK Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Takeda Pharmaceutical (TAK) in Q1 2023: 63 shares worth $1.04K. The stake represents ﹤0.01% of the portfolio and ranks #944 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in TAK as recently as Q2 2022.

Ahrens Investment Partners first reported a position in TAK in Q4 2021 and has held it in 4 quarters since. 300 funds tracked by Wall St. Rank hold TAK as of Q1 2023.

  • Ahrens Investment Partners held 63 shares of Takeda Pharmaceutical worth $1.04K as of Q1 2023.
  • Takeda Pharmaceutical was a new Ahrens Investment Partners position in Q1 2023.
  • Takeda Pharmaceutical made up ﹤0.01% of Ahrens Investment Partners's portfolio in Q1 2023, its #944 holding.
  • Ahrens Investment Partners first reported a position in Takeda Pharmaceutical in Q4 2021 and has held it in 4 quarters since.
  • 300 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.